Skip to content
Clinical Trial Events
SCOPE Summit 2027

Talk Real World Evidence track

From RWE Pilots to Decision-Grade Evidence: Building RWD into Trial Design, Operations, and Regulatory Strategy

Tue, Mar 2, 2027 · 11:30–11:55 AM EST Rosen Shingle Creek

About this session

Decision-grade RWE starts with the research question, not the dataset. To scale beyond pilots, RWD needs must be built into development planning early, shaping trial design, feasibility, endpoints, comparators, and follow-up. Sponsors need a reliable data supply chain incorporating data quality, provenance, curation, documentation, and traceability. Regardless of use case, regulatory and access needs should be anticipated upfront. The goal is repeatable, reviewable evidence—not bespoke success stories.

Speaker

  • Trevan Locke

    Director, Global Regulatory Policy and Intelligence · Amgen

    Speaker